The FDA has proposed a new set of social media guidelines that will require drug companies to tweet their products’ side-effects to the world, reports The Wall Street Journal. Though still tentative, the proposal would make it so that all the benefits and the side-effects of a companies products — even the most dangerous ones — will need to be condensed in single, 140 character tweet. If a firm concludes that adequate benefit and risk information, as well as other required information, cannot all be communicated within the same tweet, then the firm should reconsider using Twitter for the intended promotional message, the FDA wrote in the regulations.
Comments are closed.
